[1] Serrano B, Brotons M, Bosch FX, Bruni L. Epidemiology and burden of HPV-related disease. Best Pract Res Clin Obstet Gynaecol. 2018 Feb;47:14-26, http://dx.doi:10.1016/j.bpobgyn.2017.08.006.
[2] World Health Organization. Report on global sexually transmitted infection surveillance 2018 [Internet]. 2018 [cited 2019 June 19]; Available from: https://apps.who.int/iris/bitstream/handle/10665/277258/9789241565691-eng.pdf?ua=1.
[3] Rowley J, Hoorn SV, Korenromp E, Low N, Unemo M, Abu-Raddad LJ. et al. Chlamydia , gonorrhoea , trichomoniasis and syphilis: global prevalence and incidence estimates , 2016. Bull World Health Organ. 2019 Apr;97:548-562, doi: http://dx.doi.org/10.2471/BLT.18.228486
[4] Holmes KK, Sparling PF, Stamm WE, Piot P, Wasserheit JN, Corey L, et al. Sexually transmitted diseases. 4th ed. New York: McGraw-Hill Medical; 2008.
[5] Torrone EA, Morrison CS, Chen P-L, Kwok C, Francis SC, Hayes RJ, et al. Prevalence of sexually transmitted infections and bacterial vaginosis among women in sub-Saharan Africa: an individual participant data meta-analysis of 18 HIV prevention studies. PLoS Med. 2018;15(2):1002511, doi:https://doi.org/10.1371/journal.pmed.1002511
[6] Schiffman M. et al. Carcinogenic human papillomavirus infection. Nat Rev Dis Primers. 2016 Dec 1;2:16086, doi: 10.1038/nrdp.2016.86.
[7] Wendland EM, Doorbar J, Wentzensen N, de Sanjosé S, Fakhry C, Monk BJ, et al. POP-Brazil study protocol: a nationwide cross-sectional evaluation of the prevalence and genotype distribution of human papillomavirus (HPV) in Brazil. BMJ Open 2018;8(6):1–6, doi: https://doi.org/10.1136/bmjopen-2017-021170
[8] Del Prete R, Ronga L, Magrone R, Addati G. Epidemiological evaluation of human papillomavirus genotypes and their associations in multiple infections. Epidemiol Infection. 2019;147(132):1–9, doi: https://doi.org/10.1017/S0950268818003539
[9] Gravitt PE, Winer RL. Natural history of HPV infection across the lifespan: role of viral latency. Viruses. 2017 Sep;9(10):1–10, doi: 10.3390/v9100267
[10] De Sanjosé S, Brotons M, Pavón MA. The natural history of human papillomavirus infection. Best Pract Res Clin Obstet Gynaecol. 2018 Feb;47:2-13, doi: 10.1016/j.bpobgyn.2017.08.015
[11] Rader JS, Tsaih SW, Fullin D, Murray MW, Iden M, Zimmermann MT, et al. Genetic variations in human papillomavirus and cervical cancer outcomes. Int J Cancer, v. 00, p. 17–21, 2019, doi: https://doi.org/10.1002/ijc.32038
[12] Yang S, Zhao W, Wang H, Wang Y, Li J, Wu X. Trichomonas vaginalis infection-associated risk of cervical cancer: A meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2018 Sep;228:166-173, doi: 10.1016/j.ejogrb.2018.06.031
[13] Lazenby GB, Taylor PT, Badman BS, McHaki E, Korte JE, Soper DE, et al. An Association between Trichomonas vaginalis and high-risk human papillomavirus in rural Tanzanian women undergoing cervical cancer screening. Clin Ther. 2014 Jan 1;36(1):38-45, doi: 10.1016/j.clinthera.2013.11.009.
[14] Ginindza TG, Stefan CD, Tsoka-Gwegweni JM, Dlamini X, Jolly PE, Weiderpass E, et al. Prevalence and risk factors associated with sexually transmitted infections (STIs) among women of reproductive age in Swaziland. Infect Agent Cancer. 2017 May 25;12:29, doi: 10.1186/s13027-017-0140-y
[15] Muñoz-Ramírez A. et al. Prevalence of Trichomonas vaginalis and Human papillomavirus in female sex workers in Central Veracruz, Mexico. Rev Argent Microbiol. 2018;50(4): 351–358, doi: https://doi.org/10.1016/j.ram.2017.11.004
[16] Kovachev SM. Cervical cancer and vaginal microbiota changes. Arch Microbiol. 2020 Mar;202(2):323-327, doi: 10.1007/s00203-019-01747-4 .
[17] Castle PE, Giuliano AR. Chapter 4: genital tract infections , cervical inflammation, and antioxidant nutrients- assessing their roles as human papillomavirus cofactors. J Natl Cancer Inst Monogr. 2003;7234(31):29-34, doi: 10.1093/oxfordjournals.jncimonographs.a003478
[18] Ghosh I, Muwonge R, Mittal S, Banerjee D, Kundu P, Mandal R, et al. Association between high risk human papillomavirus infection and co-infection with Candida spp . and Trichomonas vaginalis in women with cervical premalignant and malignant lesions. J Clin Virol. 2017 Feb;87:43-48, doi: 10.1016/j.jcv.2016.12.007.
[19] Mercer F, Johnson PJ. Trichomonas vaginalis: pathogenesis, symbiont Interactions, and Host Cell Immune Responses. Trends Parasitol. 2018 Aug;34(8):683-693, doi: 10.1016/j.pt.2018.05.006
[20] Nikas I, Hapfelmeier A, Mollenhauer M, Angermeier D, Bettstetter M, Götz R, et al. Integrated morphologic and molecular analysis of Trichomonas vaginalis, Mycoplasma hominis, and human papillomavirus using cytologic smear preparations. Parasitol Res. 2018 May;117(5):1443-1451, doi: 10.1007/s00436-018-5829-3.
[21] Coutlée F, Gravitt P, Kornegay J, Hankins C, Richardson H, Lapointe N, et al. Use of PGMY primers in L1 consensus PCR improves detection of human papillomavirus DNA in genital samples use of PGMY primers in L1 consensus PCR improves detection of human papillomavirus DNA in genital samples. J Clin Microbiol. 2002 Mar;40(3):902-907, doi:10.1128/jcm.40.3.902-907.2002
[22] Diaz N, Dessì D, Dessole S, Fiori PL, Rappelli P. Rapid detection of coinfections by Trichomonas vaginalis, Mycoplasma hominis, and Ureaplasma urealyticum by a new multiplex polymerase chain reaction. Diagn Microbiol Infect Dis. 2010 May;67(1):30-36, doi: 10.1016/j.diagmicrobio.2009.12.022.
[23] Donders GGG,Depuydt CE,Bogers JP, Vereecken AJ. Association of trichomonas vaginalis and cytological abnormalities of the cervix in low risk women. PLoS One. 2013; 8(12):86266, doi: 10.1371/journal.pone.0086266
[24] Choi SH, Jin H, Lee KE. Prevalence of sexually transmitted pathogen coinfections in high risk-human papillomaviruses infected women in busan. Biomed Sci Letters 2019 Dec; 25:390-397, doi:https://doi.org/10.15616/BSL.2019.25.4.390
[25] Panpan Lv, Zhao F, Xu X, Xu J, Wang Q, Zhao Z. Correlation between common lower genital tract microbes and high-risk human papillomavirus infection. Can J Infect Dis Med Microbiol. 2019; 2019: 9678104, doi: https://doi.org/10.1155/2019/9678104
[26] Lugo LZA, Jacob CMB, Machado AP, Almeida FG, Ávila LS, Prata TTM, et al. Human papillomavirus and coinfections with Chlamydia trachomatis, Gardnerella vaginalis, and Trichomonas vaginalis in self-collected samples from female sex workers in the Central-Western region of Brazil. J Bras Patol Med Lab. 2018;54:46-51.
[27] Amorim AT, Marques LM, Campos GB, Lobão TN, de Souza Lino V, Cintra RC, et al. Co-infection of sexually transmitted pathogens and human papillomavirus in cervical samples of women of Brazil. BMC Infectious Diseases. 2017 Dec;17(1):769, doi: 10.1186/s12879-017-2835-5.
[28] Menon S, Broeck DV, Rossi R, Ogbe E, Harmon S, Mabeya H. Associations between vaginal infections and potential high-risk and high-risk human papillomavirus genotypes in female sex workers in Western Kenya. Clin Ther. 2016 Dec;38(12):2567-2577, doi: 10.1016/j.clinthera.2016.10.005.
[29] Zhang D, Li T, Chen L, Zhang X, Zhao G, Liu Z. Epidemiological investigation of the relationship between common lower genital tract infections and high-risk human papillomavirus infections among women in Beijing, China. PloS One. 2017;12(5):178033, doi:https://doi.org/10.1371/journal.pone.0178033
[30] Roura E, Travier N, Waterboer T, de Sanjosé S, Bosch FX, Pawlita M, et al. The influence of hormonal factors on the risk of developing cervical cancer and pre-cancer: results from the EPIC Cohort. PloS One. 2016 Jan 25;11(1):147029, doi: 10.1371/journal.pone.0147029
[31] El-Zein M, Coutlée F, Tellier PP, Roger M, Franco EL, Burchell AN, et al. Human Papillomavirus Infection and Transmission Among Couples Through Heterosexual Activity (HITCH) Cohort Study: Protocol Describing Design, Methods, and Research Goals. JMIR Res Protoc. 2019 Jan;8(1):11284, doi: 10.2196/11284
[32] Deese J, Pradhan S, Goetz H, Morrison C. Contraceptive use and the risk of sexually transmitted infection: systematic review and current perspectives. Open Access J Contracept. 2018 Nov;9:91-112, doi: 10.2147/OAJC.S135439.
[33] Santos Filho MVC, Gurgel AP, Lobo CD, Freitas AC, Silva-Neto JC, Silva LA, et al. Prevalence of human papillomavirus (HPV), distribution of HPV types, and risk factors for infection in HPV-positive women. Genet Mol Res. 2016 Jul 14;15(2):1-9, doi: 10.4238/gmr.15028315.
[34] Moscicki AB, Schiffman M, Burchell A, Albero G, Giuliano AR, Goodman MT, et al. Updating the natural history of HPV and anogenital cancer. Vaccine. 2006;24:42-51, doi: 10.1016/j.vaccine.2012.05.089.
[35] Hammes LS, Tekmal RR, Naud P, Edelweiss MI, Kirma N, Valente PT, et al. Macrophages, inflammation and risk of cervical intraepithelial neoplasia (CIN) progression clinicopathological correlation. Gynecol Oncol. 2007 Apr;105(1):157-165, doi:10.1016/j.ygyno.2006.11.023
[36] Skorstengaard M, Suhr J, Lynge E. Condom use to enhance regression of cervical intraepithelial neoplasia: study protocol for a randomized controlled trial. Trials. 2019 Aug 2;20(1):473, doi: 10.1186/s13063-019-3564-4.